Lord, Abbett & Co
NARI

Lord, Abbett & Co’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Lord, Abbett & Co’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-582,798
Closed -$37M – 645
2022
Q4 		$37M Buy
582,798
+16,941
+3% +$1.23M 0.13% 227
2022
Q3 		$41.1M Buy
565,857
+107,291
+23% +$7.99M 0.15% 184
2022
Q2 		$31.2M Buy
458,566
+133,536
+41% +$9.6M 0.11% 255
2022
Q1 		$29.5M Buy
+325,030
New +$26.6M 0.08% 314
2021
Q3 		– Sell
-827,205
Closed -$77.2M – 706
2021
Q2 		$77.2M Sell
827,205
-154,369
-16% -$15M 0.19% 164
2021
Q1 		$105M Buy
981,574
+356,174
+57% +$37M 0.27% 109
2020
Q4 		$54.6M Buy
625,400
+541,283
+643% +$38.2M 0.14% 231
2020
Q3 		$5.81M Sell
84,117
-50,127
-37% -$3.22M 0.02% 551
2020
Q2 		$6.5M Buy
+134,244
New +$6.41M 0.02% 537

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Lord, Abbett & Co's NARI Position: Q1 2023 in Review

Lord, Abbett & Co sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2023, closing a stake of 582,798 shares — an estimated $37M sold.

Lord, Abbett & Co first reported a position in NARI in Q2 2020 and held it in 9 quarters. The position peaked at $105M in Q1 2021. 256 funds tracked by Wall St. Rank hold NARI as of Q1 2023.

  • Lord, Abbett & Co reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 582,798 Inari Medical, Inc. Common Stock shares in Q1 2023, an estimated $37M.
  • Lord, Abbett & Co first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
  • Lord, Abbett & Co's Inari Medical, Inc. Common Stock position peaked at $105M in Q1 2021.
  • 256 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2023.

Based on Lord, Abbett & Co's 13F filing for Q1 2023, filed 12 May 2023.